Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-8010 in Overactive Bladder
NCT03566134Phase 2Completed
- Sponsor
- Dong-A ST
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of velufenacin in overactive bladder (OAB), sponsored by Dong-A ST. Started Jul 2018; status: completed.
02
Drugs
velufenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03566134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566134.